News · Brain & Mental Health

The IBS hypnotherapy app lost to a human, but not to nothing

A Gut trial randomized 230 people with IBS to a therapist, an app or psychoeducation. The app failed its non-inferiority test against the therapist and still beat the control.

By Live Well Editorial Team · July 29, 2026

A woman resting on a sofa with headphones on and her eyes closed — Credit: Photo: Ivan S / Pexels

Based on a peer-reviewed randomized trial in Gut

Summary

A multicenter three-armed randomized trial assigned 230 patients with IBS to 12 weeks of in-person hypnotherapy, smartphone self-guided hypnotherapy, or online psychoeducation, publishing in Gut.
Mean age was 38.2 years and 70.4% were female. Diagnosis used the Rome IV criteria.
The endpoint was the FDA definition of abdominal pain response: at least a 30% reduction in worst daily pain in at least 2 of 4 follow-up weeks.
Response rates were 48% for the therapist, 33% for the app and 22% for psychoeducation.
Non-inferiority of the app was NOT shown: the difference was -14.7% (95% CI, -29.3% to 0.9%) against a 10% margin.
In-person hypnotherapy beat psychoeducation at week 16 (OR, 3.48; 95% CI, 1.68-7.20).
At 6-month follow-up both hypnotherapy arms beat psychoeducation (OR, 3.11 and OR, 4.68).
Neither hypnotherapy arm changed psychological symptoms compared with the others.

Gut-directed hypnotherapy genuinely works for irritable bowel syndrome. The problem has never been the evidence; it is that there are not enough trained therapists, and the ones who exist cost money.

An app is the obvious answer, and a trial in Gut tested whether it holds up. The honest result is a split verdict, and both halves are informative.

The access problem this was built to solve

The authors state the setup plainly. Hypnotherapy is an evidence-based therapy recommended for IBS, but access to therapist-led hypnotherapy is limited by costs and availability.

That is the situation for a great many effective psychological treatments. They work, and most people who need them will never get them. So the question is not whether a self-guided version is as good as a human. It is whether a self-guided version is good enough to be worth offering to the people a human will never reach.

The trial studied the effectiveness of smartphone-based self-guided hypnotherapy versus in-person therapist-delivered hypnotherapy, with a third arm as a control.

How it was run

Three arms, and the third one matters.

The trial included patients with IBS diagnosed by Rome IV criteria, aged 16-75, across multiple centers. Patients were assigned to 12-week in-person therapist-delivered hypnotherapy, smartphone-based self-guided hypnotherapy or online self-guided psychoeducation.

Without that psychoeducation arm, an app that performed moderately would be uninterpretable: you could not tell whether it was working or whether people simply improve over twelve weeks. IBS symptoms fluctuate, and placebo response in gut trials is notoriously high.

The measure was the regulator’s, not the researchers’. The primary endpoint was abdominal pain response per the FDA definition: at least a 30% reduction from baseline in the weekly average of worst daily abdominal pain in at least 2 out of 4 follow-up weeks. A total of 230 patients were enrolled and assigned.

The result the trial was designed to find

The three response rates line up in the order you would guess, with meaningful gaps.

FDA abdominal pain response rates were 48% for in-person therapist-delivered hypnotherapy, 33% for smartphone-based self-guided hypnotherapy and 22% for psychoeducation.

Then the formal test. Non-inferiority of online to in-person hypnotherapy could not be shown, with a difference of -14.7% and an interval running from -29.3% to 0.9%.

Read carefully, that is a specific failure. The trial set a 10% margin in advance for how much worse the app could be and still count as acceptable. The observed gap was larger than that, and the uncertainty around it larger still. The app did not clear the bar it was measured against.

The result that makes the app interesting anyway

Failing to match a therapist is not the same as failing.

In-person hypnotherapy was more effective than psychoeducation at week 16. And at 6-month follow-up, both hypnotherapy groups were more effective than psychoeducation, with estimates of 3.11 for the therapist arm and 4.68 for the app.

The app’s six-month estimate being the larger of the two should not be over-read, given the intervals overlap heavily. What it does establish is that the app’s benefit did not evaporate when the twelve weeks ended.

Set against the access problem, a treatment delivering a 33% response rate at close to zero marginal cost per patient is not a consolation prize. It is a different product for a different problem.

The finding that says something about mechanism

One result quietly rules out an easy explanation. There were no significant treatment effects on psychological symptoms between groups.

If hypnotherapy for IBS worked mainly by reducing anxiety, psychological measures should have improved alongside the pain. They did not. That points to something more specific about how the gut reports sensation, rather than a general calming effect, which is what the gut-directed protocol was designed around in the first place.

What the trial cannot show

Two hundred and thirty patients across three arms means each comparison rests on a modest group, which is why the non-inferiority interval is as wide as it is. A larger trial might have shown the app closer to the therapist, or further away.

The population also skews young and female: mean age 38.2 years, 70.4% female. That is typical of IBS clinics, and still a limit on who these numbers describe.

The authors’ conclusion holds both halves at once: the trial could not demonstrate non-inferiority of smartphone-based self-guided hypnotherapy compared with in-person therapist-delivered hypnotherapy in reducing abdominal pain, however substantial response rates for smartphone-based self-guided hypnotherapy highlight its potential as a broadly applicable and cost-effective alternative.

Which is the right way round. The app lost to a person, and it is still better than what most people with IBS are currently offered.

People also ask

Why is hypnotherapy a mainstream treatment for IBS?

Because it has evidence behind it, which surprises people. Gut-directed hypnotherapy is a structured protocol focused on gut sensation and the gut-brain connection, not stage hypnosis, and it appears in clinical guidelines for IBS as an option after diet and first-line drugs. The paper describes it as an evidence-based therapy recommended for IBS, with access limited by costs and availability. That access problem is the reason to test an app.

What does 'non-inferiority was not shown' actually mean?

It means the trial could not rule out that the app is meaningfully worse. Non-inferiority trials set a margin in advance for how much worse a cheaper option may be while still counting as acceptable; here it was 10%. The observed difference was 14.7% in the therapist's favor, and the interval ran from 29.3% worse to 0.9% better. Because that range extends past the 10% margin, the app failed the test. It does not mean the app was proven worse, only that the trial could not show it was close enough.

So is the app worthless?

No, and that is the more useful half of the result. A 33% response rate against 22% for psychoeducation is a real difference, and at six-month follow-up both hypnotherapy arms outperformed psychoeducation, with the app's estimate actually the larger of the two. The authors describe the response rates as substantial and highlight its potential as a broadly applicable and cost-effective alternative. Failing to match a therapist is not the same as failing.

Why measure abdominal pain rather than overall symptoms?

Because it is the regulator-approved standard and it resists wishful reporting. The FDA definition requires at least a 30% reduction in the weekly average of worst daily abdominal pain, in at least 2 out of 4 follow-up weeks, which is a harder bar than asking someone whether they feel better. The trial also tracked symptom-severity scores as a secondary measure.

Did it help anxiety or low mood?

No, and that is worth noting because it undercuts a common assumption. There were no significant treatment effects on psychological symptoms between groups. If hypnotherapy worked purely by making people calmer, you would expect psychological measures to move. They did not, which points at something more specific to gut sensation than to general mood.